Citadel Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.8M | Buy |
|
|||||
|
2025
Q1 | $1.29M | Buy |
|
|||||
|
2024
Q4 | $241K | Sell |
|
|||||
|
2024
Q3 | $6.91M | Buy |
|
|||||
|
2024
Q2 | $5.46M | Sell |
|
|||||
|
2024
Q1 | $8.02M | Buy |
|
|||||
|
2023
Q4 | $811K | Sell |
|
|||||
|
2023
Q3 | $4.74M | Sell |
|
|||||
|
2023
Q2 | $4.36M | Sell |
|
|||||
|
2023
Q1 | $4.59M | Buy |
|
|||||
|
2022
Q4 | $684K | Sell |
|
|||||
|
2022
Q3 | $790K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.09M | Sell |
|
|||||
|
2021
Q4 | $1.84M | Buy |
|
|||||
|
2021
Q3 | $783K | Sell |
|
|||||
|
2021
Q2 | $1.14M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $661K | Buy |
|
|||||
|
2020
Q3 | $613K | Buy |
|
|||||
|
2020
Q2 | $579K | Sell |
|
|||||
|
2020
Q1 | $526K | Buy |
|
|||||
|
2019
Q4 | $701K | Buy |
|
|||||
|
2019
Q3 | $416K | Buy |
|
|||||
|
2019
Q2 | $295K | Buy |
|